AltheaDx | GenomeWeb

AltheaDx

The funding comes several months after the drug metabolism testing company withdrew a planned $74.3 million initial public offering. 

As part of the deal, AltheaDx's IDgenetix genetic testing will be integrated into Sinfonia's medication therapy management programs.

In an SEC document, the company said that current terms were not attractive enough for it to continue with a public offering. 

The molecular diagnostics firm anticipates fetching between $12 and $14 per share in its IPO for net proceeds of $52.2 million at the midpoint price of $13 per share. 

The firm offers a portfolio of genetic tests to help clinicians tailor treatments for patients suffering from cardiovascular disease, neuropsychiatric disorders, and pain. 

BioTheranostics Nicolas Barthelemy its new president and CEO. He succeeds Richard Ding, who will remain chairman of the board of bioTheranostics in addition to heading the Asia Pacific operations for parent company bioMérieux.

NEW YORK (GenomeWeb) – AltheaDx's suite of pharmacogenetic tests, called IDgenetix, has been approved by the New York Department of Health, enabling the molecular diagnostics firm to sell the tests in all 50 US states.

NEW YORK (GenomeWeb) – AltheaDx has received accreditation from the College of American Pathologists, the San Diego firm announced today.

NEW YORK (GenomeWeb News) – Life Technologies has added 11 new members from the US and Canada to its Ion AmpliSeq Exome Certified Service Provider program, the company said today.

Life Technologies has named both Asuragen and AltheaDx as authorized customer service providers for sequencing on its Ion Torrent PGM platform.

Pages

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.